RT @DrNancyOlivieri: About that "science" @cochranecollab documented the risks of #deferiprone vs licensed Rx: -2.6 fold increased risk of…
RT @DrNancyOlivieri: About that "science" @cochranecollab documented the risks of #deferiprone vs licensed Rx: -2.6 fold increased risk of…
RT @DrNancyOlivieri: About that "science" @cochranecollab documented the risks of #deferiprone vs licensed Rx: -2.6 fold increased risk of…
RT @DrNancyOlivieri: About that "science" @cochranecollab documented the risks of #deferiprone vs licensed Rx: -2.6 fold increased risk of…
RT @DrNancyOlivieri: About that "science" @cochranecollab documented the risks of #deferiprone vs licensed Rx: -2.6 fold increased risk of…
RT @DrNancyOlivieri: About that "science" @cochranecollab documented the risks of #deferiprone vs licensed Rx: -2.6 fold increased risk of…
About that "science" @cochranecollab documented the risks of #deferiprone vs licensed Rx: -2.6 fold increased risk of joint pain -8.9 fold increased risk of liver injury -11.7 fold increased risk of gut problems https://t.co/VatEQpYhwV No evidence that pat
#Thalassaemia chelation therapies-updated #Cochrane reviews support current recommendations http://t.co/hDpeyhiB3Y & http://t.co/abjk2DFwfU